[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Cefuroxim Market - Global Outlook and Forecast 2021-2027

April 2021 | 109 pages | ID: C0C73199E83FEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Cefuroxim in Global, including the following market information:

Global Cefuroxim Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Cefuroxim market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cefuroxim companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cefuroxim Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Cefuroxim Market Segment Percentages, By Type, 2020 (%)
  • Injection
  • Tablets
  • Capsule
China Cefuroxim Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Cefuroxim Market Segment Percentages, By Application, 2020 (%)
  • Respiratory Tract Infection
  • Otolaryngological Infection
  • Urinary Tract Infection
  • Skin And Soft Tissue Infections
  • Bone And Joint Infections
  • Gonorrhea
  • Other
Global Cefuroxim Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Cefuroxim Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Cefuroxim Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Cefuroxim Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Apotex
  • Esseti Farmaceutici
  • GSK
  • Lilly
  • Medochemie
  • Northeast Pharmaceutical
  • NCPC
  • Nanchang Lijian Pharmaceutical
  • Sichuan Pharmaceutical
  • Shandong Runze Pharmaceutical
  • Shandong Luoxin Pharmaceutical Group
  • Guangdong Bozhou Pharmaceutical
  • Guangdong Jincheng Jinsu Pharmaceutical
  • Guangzhou Baiyunshan Tianxin Pharmaceutical
  • Guangxi Kelun Pharmaceutical
  • Yuekang Pharmaceutical Group
  • Shantou Jinshi Injection
  • Zhejiang Yatai Pharmaceutical
  • Shenzhen Xinlitai Pharmaceutical
  • Shenzhen Huarun Jiuxin Pharmaceutical
  • Zhuhai Union Pharmaceutical
  • Ruiyang Pharmaceutical
  • Fujian Fukang Pharmaceutical
  • Suzhou Erye Pharmaceutical
  • furen Pharmaceutical Group
  • Chongqing Kerui Pharmaceutical Group
  • Shaanxi Xidunsi Pharmaceutical
  • Qilu Pharmaceutical
  • Shandong Zibo Xinda Pharmaceutical
  • Guangzhou Nanxin Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cefuroxim Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cefuroxim Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CEFUROXIM OVERALL MARKET SIZE

2.1 Global Cefuroxim Market Size: 2021 VS 2027
2.2 Global Cefuroxim Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cefuroxim Players in Global Market
3.2 Top Global Cefuroxim Companies Ranked by Revenue
3.3 Global Cefuroxim Revenue by Companies
3.4 Top 3 and Top 5 Cefuroxim Companies in Global Market, by Revenue in 2020
3.5 Global Companies Cefuroxim Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cefuroxim Players in Global Market
  3.6.1 List of Global Tier 1 Cefuroxim Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cefuroxim Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Cefuroxim Market Size Markets, 2021 & 2027
  4.1.2 Injection
  4.1.3 Tablets
  4.1.4 Capsule
4.2 By Type - Global Cefuroxim Revenue & Forecasts
  4.2.1 By Type - Global Cefuroxim Revenue, 2016-2021
  4.2.2 By Type - Global Cefuroxim Revenue, 2022-2027
  4.2.3 By Type - Global Cefuroxim Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cefuroxim Market Size, 2021 & 2027
  5.1.2 Respiratory Tract Infection
  5.1.3 Otolaryngological Infection
  5.1.4 Urinary Tract Infection
  5.1.5 Skin And Soft Tissue Infections
  5.1.6 Bone And Joint Infections
  5.1.7 Gonorrhea
  5.1.8 Other
5.2 By Application - Global Cefuroxim Revenue & Forecasts
  5.2.1 By Application - Global Cefuroxim Revenue, 2016-2021
  5.2.2 By Application - Global Cefuroxim Revenue, 2022-2027
  5.2.3 By Application - Global Cefuroxim Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Cefuroxim Market Size, 2021 & 2027
6.2 By Region - Global Cefuroxim Revenue & Forecasts
  6.2.1 By Region - Global Cefuroxim Revenue, 2016-2021
  6.2.2 By Region - Global Cefuroxim Revenue, 2022-2027
  6.2.3 By Region - Global Cefuroxim Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Cefuroxim Revenue, 2016-2027
  6.3.2 US Cefuroxim Market Size, 2016-2027
  6.3.3 Canada Cefuroxim Market Size, 2016-2027
  6.3.4 Mexico Cefuroxim Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Cefuroxim Revenue, 2016-2027
  6.4.2 Germany Cefuroxim Market Size, 2016-2027
  6.4.3 France Cefuroxim Market Size, 2016-2027
  6.4.4 U.K. Cefuroxim Market Size, 2016-2027
  6.4.5 Italy Cefuroxim Market Size, 2016-2027
  6.4.6 Russia Cefuroxim Market Size, 2016-2027
  6.4.7 Nordic Countries Cefuroxim Market Size, 2016-2027
  6.4.8 Benelux Cefuroxim Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Cefuroxim Revenue, 2016-2027
  6.5.2 China Cefuroxim Market Size, 2016-2027
  6.5.3 Japan Cefuroxim Market Size, 2016-2027
  6.5.4 South Korea Cefuroxim Market Size, 2016-2027
  6.5.5 Southeast Asia Cefuroxim Market Size, 2016-2027
  6.5.6 India Cefuroxim Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Cefuroxim Revenue, 2016-2027
  6.6.2 Brazil Cefuroxim Market Size, 2016-2027
  6.6.3 Argentina Cefuroxim Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cefuroxim Revenue, 2016-2027
  6.7.2 Turkey Cefuroxim Market Size, 2016-2027
  6.7.3 Israel Cefuroxim Market Size, 2016-2027
  6.7.4 Saudi Arabia Cefuroxim Market Size, 2016-2027
  6.7.5 UAE Cefuroxim Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Apotex
  7.1.1 Apotex Corporate Summary
  7.1.2 Apotex Business Overview
  7.1.3 Apotex Cefuroxim Major Product Offerings
  7.1.4 Apotex Cefuroxim Revenue in Global (2016-2021)
  7.1.5 Apotex Key News
7.2 Esseti Farmaceutici
  7.2.1 Esseti Farmaceutici Corporate Summary
  7.2.2 Esseti Farmaceutici Business Overview
  7.2.3 Esseti Farmaceutici Cefuroxim Major Product Offerings
  7.2.4 Esseti Farmaceutici Cefuroxim Revenue in Global (2016-2021)
  7.2.5 Esseti Farmaceutici Key News
7.3 GSK
  7.3.1 GSK Corporate Summary
  7.3.2 GSK Business Overview
  7.3.3 GSK Cefuroxim Major Product Offerings
  7.3.4 GSK Cefuroxim Revenue in Global (2016-2021)
  7.3.5 GSK Key News
7.4 Lilly
  7.4.1 Lilly Corporate Summary
  7.4.2 Lilly Business Overview
  7.4.3 Lilly Cefuroxim Major Product Offerings
  7.4.4 Lilly Cefuroxim Revenue in Global (2016-2021)
  7.4.5 Lilly Key News
7.5 Medochemie
  7.5.1 Medochemie Corporate Summary
  7.5.2 Medochemie Business Overview
  7.5.3 Medochemie Cefuroxim Major Product Offerings
  7.5.4 Medochemie Cefuroxim Revenue in Global (2016-2021)
  7.5.5 Medochemie Key News
7.6 Northeast Pharmaceutical
  7.6.1 Northeast Pharmaceutical Corporate Summary
  7.6.2 Northeast Pharmaceutical Business Overview
  7.6.3 Northeast Pharmaceutical Cefuroxim Major Product Offerings
  7.6.4 Northeast Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.6.5 Northeast Pharmaceutical Key News
7.7 NCPC
  7.7.1 NCPC Corporate Summary
  7.7.2 NCPC Business Overview
  7.7.3 NCPC Cefuroxim Major Product Offerings
  7.4.4 NCPC Cefuroxim Revenue in Global (2016-2021)
  7.7.5 NCPC Key News
7.8 Nanchang Lijian Pharmaceutical
  7.8.1 Nanchang Lijian Pharmaceutical Corporate Summary
  7.8.2 Nanchang Lijian Pharmaceutical Business Overview
  7.8.3 Nanchang Lijian Pharmaceutical Cefuroxim Major Product Offerings
  7.8.4 Nanchang Lijian Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.8.5 Nanchang Lijian Pharmaceutical Key News
7.9 Sichuan Pharmaceutical
  7.9.1 Sichuan Pharmaceutical Corporate Summary
  7.9.2 Sichuan Pharmaceutical Business Overview
  7.9.3 Sichuan Pharmaceutical Cefuroxim Major Product Offerings
  7.9.4 Sichuan Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.9.5 Sichuan Pharmaceutical Key News
7.10 Shandong Runze Pharmaceutical
  7.10.1 Shandong Runze Pharmaceutical Corporate Summary
  7.10.2 Shandong Runze Pharmaceutical Business Overview
  7.10.3 Shandong Runze Pharmaceutical Cefuroxim Major Product Offerings
  7.10.4 Shandong Runze Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.10.5 Shandong Runze Pharmaceutical Key News
7.11 Shandong Luoxin Pharmaceutical Group
  7.11.1 Shandong Luoxin Pharmaceutical Group Corporate Summary
  7.11.2 Shandong Luoxin Pharmaceutical Group Business Overview
  7.11.3 Shandong Luoxin Pharmaceutical Group Cefuroxim Major Product Offerings
  7.11.4 Shandong Luoxin Pharmaceutical Group Cefuroxim Revenue in Global (2016-2021)
  7.11.5 Shandong Luoxin Pharmaceutical Group Key News
7.12 Guangdong Bozhou Pharmaceutical
  7.12.1 Guangdong Bozhou Pharmaceutical Corporate Summary
  7.12.2 Guangdong Bozhou Pharmaceutical Business Overview
  7.12.3 Guangdong Bozhou Pharmaceutical Cefuroxim Major Product Offerings
  7.12.4 Guangdong Bozhou Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.12.5 Guangdong Bozhou Pharmaceutical Key News
7.13 Guangdong Jincheng Jinsu Pharmaceutical
  7.13.1 Guangdong Jincheng Jinsu Pharmaceutical Corporate Summary
  7.13.2 Guangdong Jincheng Jinsu Pharmaceutical Business Overview
  7.13.3 Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Major Product Offerings
  7.13.4 Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.13.5 Guangdong Jincheng Jinsu Pharmaceutical Key News
7.14 Guangzhou Baiyunshan Tianxin Pharmaceutical
  7.14.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Corporate Summary
  7.14.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Business Overview
  7.14.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Major Product Offerings
  7.14.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.14.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Key News
7.15 Guangxi Kelun Pharmaceutical
  7.15.1 Guangxi Kelun Pharmaceutical Corporate Summary
  7.15.2 Guangxi Kelun Pharmaceutical Business Overview
  7.15.3 Guangxi Kelun Pharmaceutical Cefuroxim Major Product Offerings
  7.15.4 Guangxi Kelun Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.15.5 Guangxi Kelun Pharmaceutical Key News
7.16 Yuekang Pharmaceutical Group
  7.16.1 Yuekang Pharmaceutical Group Corporate Summary
  7.16.2 Yuekang Pharmaceutical Group Business Overview
  7.16.3 Yuekang Pharmaceutical Group Cefuroxim Major Product Offerings
  7.16.4 Yuekang Pharmaceutical Group Cefuroxim Revenue in Global (2016-2021)
  7.16.5 Yuekang Pharmaceutical Group Key News
7.17 Shantou Jinshi Injection
  7.17.1 Shantou Jinshi Injection Corporate Summary
  7.17.2 Shantou Jinshi Injection Business Overview
  7.17.3 Shantou Jinshi Injection Cefuroxim Major Product Offerings
  7.17.4 Shantou Jinshi Injection Cefuroxim Revenue in Global (2016-2021)
  7.17.5 Shantou Jinshi Injection Key News
7.18 Zhejiang Yatai Pharmaceutical
  7.18.1 Zhejiang Yatai Pharmaceutical Corporate Summary
  7.18.2 Zhejiang Yatai Pharmaceutical Business Overview
  7.18.3 Zhejiang Yatai Pharmaceutical Cefuroxim Major Product Offerings
  7.18.4 Zhejiang Yatai Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.18.5 Zhejiang Yatai Pharmaceutical Key News
7.19 Shenzhen Xinlitai Pharmaceutical
  7.19.1 Shenzhen Xinlitai Pharmaceutical Corporate Summary
  7.19.2 Shenzhen Xinlitai Pharmaceutical Business Overview
  7.19.3 Shenzhen Xinlitai Pharmaceutical Cefuroxim Major Product Offerings
  7.19.4 Shenzhen Xinlitai Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.19.5 Shenzhen Xinlitai Pharmaceutical Key News
7.20 Shenzhen Huarun Jiuxin Pharmaceutical
  7.20.1 Shenzhen Huarun Jiuxin Pharmaceutical Corporate Summary
  7.20.2 Shenzhen Huarun Jiuxin Pharmaceutical Business Overview
  7.20.3 Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Major Product Offerings
  7.20.4 Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.20.5 Shenzhen Huarun Jiuxin Pharmaceutical Key News
7.21 Zhuhai Union Pharmaceutical
  7.21.1 Zhuhai Union Pharmaceutical Corporate Summary
  7.21.2 Zhuhai Union Pharmaceutical Business Overview
  7.21.3 Zhuhai Union Pharmaceutical Cefuroxim Major Product Offerings
  7.21.4 Zhuhai Union Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.21.5 Zhuhai Union Pharmaceutical Key News
7.22 Ruiyang Pharmaceutical
  7.22.1 Ruiyang Pharmaceutical Corporate Summary
  7.22.2 Ruiyang Pharmaceutical Business Overview
  7.22.3 Ruiyang Pharmaceutical Cefuroxim Major Product Offerings
  7.22.4 Ruiyang Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.22.5 Ruiyang Pharmaceutical Key News
7.23 Fujian Fukang Pharmaceutical
  7.23.1 Fujian Fukang Pharmaceutical Corporate Summary
  7.23.2 Fujian Fukang Pharmaceutical Business Overview
  7.23.3 Fujian Fukang Pharmaceutical Cefuroxim Major Product Offerings
  7.23.4 Fujian Fukang Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.23.5 Fujian Fukang Pharmaceutical Key News
7.24 Suzhou Erye Pharmaceutical
  7.24.1 Suzhou Erye Pharmaceutical Corporate Summary
  7.24.2 Suzhou Erye Pharmaceutical Business Overview
  7.24.3 Suzhou Erye Pharmaceutical Cefuroxim Major Product Offerings
  7.24.4 Suzhou Erye Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.24.5 Suzhou Erye Pharmaceutical Key News
7.25 furen Pharmaceutical Group
  7.25.1 furen Pharmaceutical Group Corporate Summary
  7.25.2 furen Pharmaceutical Group Business Overview
  7.25.3 furen Pharmaceutical Group Cefuroxim Major Product Offerings
  7.25.4 furen Pharmaceutical Group Cefuroxim Revenue in Global (2016-2021)
  7.25.5 furen Pharmaceutical Group Key News
7.26 Chongqing Kerui Pharmaceutical Group
  7.26.1 Chongqing Kerui Pharmaceutical Group Corporate Summary
  7.26.2 Chongqing Kerui Pharmaceutical Group Business Overview
  7.26.3 Chongqing Kerui Pharmaceutical Group Cefuroxim Major Product Offerings
  7.26.4 Chongqing Kerui Pharmaceutical Group Cefuroxim Revenue in Global (2016-2021)
  7.26.5 Chongqing Kerui Pharmaceutical Group Key News
7.27 Shaanxi Xidunsi Pharmaceutical
  7.27.1 Shaanxi Xidunsi Pharmaceutical Corporate Summary
  7.27.2 Shaanxi Xidunsi Pharmaceutical Business Overview
  7.27.3 Shaanxi Xidunsi Pharmaceutical Cefuroxim Major Product Offerings
  7.27.4 Shaanxi Xidunsi Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.27.5 Shaanxi Xidunsi Pharmaceutical Key News
7.28 Qilu Pharmaceutical
  7.28.1 Qilu Pharmaceutical Corporate Summary
  7.28.2 Qilu Pharmaceutical Business Overview
  7.28.3 Qilu Pharmaceutical Cefuroxim Major Product Offerings
  7.28.4 Qilu Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.28.5 Qilu Pharmaceutical Key News
7.29 Shandong Zibo Xinda Pharmaceutical
  7.29.1 Shandong Zibo Xinda Pharmaceutical Corporate Summary
  7.29.2 Shandong Zibo Xinda Pharmaceutical Business Overview
  7.29.3 Shandong Zibo Xinda Pharmaceutical Cefuroxim Major Product Offerings
  7.29.4 Shandong Zibo Xinda Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.29.5 Shandong Zibo Xinda Pharmaceutical Key News
7.30 Guangzhou Nanxin Pharmaceutical
  7.30.1 Guangzhou Nanxin Pharmaceutical Corporate Summary
  7.30.2 Guangzhou Nanxin Pharmaceutical Business Overview
  7.30.3 Guangzhou Nanxin Pharmaceutical Cefuroxim Major Product Offerings
  7.30.4 Guangzhou Nanxin Pharmaceutical Cefuroxim Revenue in Global (2016-2021)
  7.30.5 Guangzhou Nanxin Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Cefuroxim Market Opportunities & Trends in Global Market
Table 2. Cefuroxim Market Drivers in Global Market
Table 3. Cefuroxim Market Restraints in Global Market
Table 4. Key Players of Cefuroxim in Global Market
Table 5. Top Cefuroxim Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Cefuroxim Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Cefuroxim Revenue Share by Companies, 2016-2021
Table 8. Global Companies Cefuroxim Product Type
Table 9. List of Global Tier 1 Cefuroxim Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cefuroxim Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Cefuroxim Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Cefuroxim Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Cefuroxim Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Cefuroxim Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Cefuroxim Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Cefuroxim Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Cefuroxim Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Cefuroxim Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Cefuroxim Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Cefuroxim Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Cefuroxim Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Cefuroxim Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Cefuroxim Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Cefuroxim Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Cefuroxim Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Cefuroxim Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Cefuroxim Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Cefuroxim Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Cefuroxim Revenue, (US$, Mn), 2022-2027
Table 30. Apotex Corporate Summary
Table 31. Apotex Cefuroxim Product Offerings
Table 32. Apotex Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 33. Esseti Farmaceutici Corporate Summary
Table 34. Esseti Farmaceutici Cefuroxim Product Offerings
Table 35. Esseti Farmaceutici Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 36. GSK Corporate Summary
Table 37. GSK Cefuroxim Product Offerings
Table 38. GSK Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 39. Lilly Corporate Summary
Table 40. Lilly Cefuroxim Product Offerings
Table 41. Lilly Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 42. Medochemie Corporate Summary
Table 43. Medochemie Cefuroxim Product Offerings
Table 44. Medochemie Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 45. Northeast Pharmaceutical Corporate Summary
Table 46. Northeast Pharmaceutical Cefuroxim Product Offerings
Table 47. Northeast Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 48. NCPC Corporate Summary
Table 49. NCPC Cefuroxim Product Offerings
Table 50. NCPC Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 51. Nanchang Lijian Pharmaceutical Corporate Summary
Table 52. Nanchang Lijian Pharmaceutical Cefuroxim Product Offerings
Table 53. Nanchang Lijian Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 54. Sichuan Pharmaceutical Corporate Summary
Table 55. Sichuan Pharmaceutical Cefuroxim Product Offerings
Table 56. Sichuan Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 57. Shandong Runze Pharmaceutical Corporate Summary
Table 58. Shandong Runze Pharmaceutical Cefuroxim Product Offerings
Table 59. Shandong Runze Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 60. Shandong Luoxin Pharmaceutical Group Corporate Summary
Table 61. Shandong Luoxin Pharmaceutical Group Cefuroxim Product Offerings
Table 62. Shandong Luoxin Pharmaceutical Group Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 63. Guangdong Bozhou Pharmaceutical Corporate Summary
Table 64. Guangdong Bozhou Pharmaceutical Cefuroxim Product Offerings
Table 65. Guangdong Bozhou Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 66. Guangdong Jincheng Jinsu Pharmaceutical Corporate Summary
Table 67. Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Product Offerings
Table 68. Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 69. Guangzhou Baiyunshan Tianxin Pharmaceutical Corporate Summary
Table 70. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Product Offerings
Table 71. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 72. Guangxi Kelun Pharmaceutical Corporate Summary
Table 73. Guangxi Kelun Pharmaceutical Cefuroxim Product Offerings
Table 74. Guangxi Kelun Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 75. Yuekang Pharmaceutical Group Corporate Summary
Table 76. Yuekang Pharmaceutical Group Cefuroxim Product Offerings
Table 77. Yuekang Pharmaceutical Group Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 78. Shantou Jinshi Injection Corporate Summary
Table 79. Shantou Jinshi Injection Cefuroxim Product Offerings
Table 80. Shantou Jinshi Injection Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 81. Zhejiang Yatai Pharmaceutical Corporate Summary
Table 82. Zhejiang Yatai Pharmaceutical Cefuroxim Product Offerings
Table 83. Zhejiang Yatai Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 84. Shenzhen Xinlitai Pharmaceutical Corporate Summary
Table 85. Shenzhen Xinlitai Pharmaceutical Cefuroxim Product Offerings
Table 86. Shenzhen Xinlitai Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 87. Shenzhen Huarun Jiuxin Pharmaceutical Corporate Summary
Table 88. Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Product Offerings
Table 89. Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 90. Zhuhai Union Pharmaceutical Corporate Summary
Table 91. Zhuhai Union Pharmaceutical Cefuroxim Product Offerings
Table 92. Zhuhai Union Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 93. Ruiyang Pharmaceutical Corporate Summary
Table 94. Ruiyang Pharmaceutical Cefuroxim Product Offerings
Table 95. Ruiyang Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 96. Fujian Fukang Pharmaceutical Corporate Summary
Table 97. Fujian Fukang Pharmaceutical Cefuroxim Product Offerings
Table 98. Fujian Fukang Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 99. Suzhou Erye Pharmaceutical Corporate Summary
Table 100. Suzhou Erye Pharmaceutical Cefuroxim Product Offerings
Table 101. Suzhou Erye Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 102. furen Pharmaceutical Group Corporate Summary
Table 103. furen Pharmaceutical Group Cefuroxim Product Offerings
Table 104. furen Pharmaceutical Group Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 105. Chongqing Kerui Pharmaceutical Group Corporate Summary
Table 106. Chongqing Kerui Pharmaceutical Group Cefuroxim Product Offerings
Table 107. Chongqing Kerui Pharmaceutical Group Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 108. Shaanxi Xidunsi Pharmaceutical Corporate Summary
Table 109. Shaanxi Xidunsi Pharmaceutical Cefuroxim Product Offerings
Table 110. Shaanxi Xidunsi Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 111. Qilu Pharmaceutical Corporate Summary
Table 112. Qilu Pharmaceutical Cefuroxim Product Offerings
Table 113. Qilu Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 114. Shandong Zibo Xinda Pharmaceutical Corporate Summary
Table 115. Shandong Zibo Xinda Pharmaceutical Cefuroxim Product Offerings
Table 116. Shandong Zibo Xinda Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)
Table 117. Guangzhou Nanxin Pharmaceutical Corporate Summary
Table 118. Guangzhou Nanxin Pharmaceutical Cefuroxim Product Offerings
Table 119. Guangzhou Nanxin Pharmaceutical Cefuroxim Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Cefuroxim Segment by Type
Figure 2. Cefuroxim Segment by Application
Figure 3. Global Cefuroxim Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Cefuroxim Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Cefuroxim Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cefuroxim Revenue in 2020
Figure 8. By Type - Global Cefuroxim Revenue Market Share, 2016-2027
Figure 9. By Application - Global Cefuroxim Revenue Market Share, 2016-2027
Figure 10. By Region - Global Cefuroxim Revenue Market Share, 2016-2027
Figure 11. By Country - North America Cefuroxim Revenue Market Share, 2016-2027
Figure 12. US Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Cefuroxim Revenue Market Share, 2016-2027
Figure 16. Germany Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 17. France Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Cefuroxim Revenue Market Share, 2016-2027
Figure 24. China Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 28. India Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Cefuroxim Revenue Market Share, 2016-2027
Figure 30. Brazil Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Cefuroxim Revenue Market Share, 2016-2027
Figure 33. Turkey Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Cefuroxim Revenue, (US$, Mn), 2016-2027
Figure 37. Apotex Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Esseti Farmaceutici Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. GSK Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Lilly Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Medochemie Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Northeast Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. NCPC Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Nanchang Lijian Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sichuan Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Shandong Runze Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Shandong Luoxin Pharmaceutical Group Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Guangdong Bozhou Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Guangdong Jincheng Jinsu Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Guangxi Kelun Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. Yuekang Pharmaceutical Group Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. Shantou Jinshi Injection Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 54. Zhejiang Yatai Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 55. Shenzhen Xinlitai Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 56. Shenzhen Huarun Jiuxin Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 57. Zhuhai Union Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 58. Ruiyang Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 59. Fujian Fukang Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 60. Suzhou Erye Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 61. furen Pharmaceutical Group Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 62. Chongqing Kerui Pharmaceutical Group Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 63. Shaanxi Xidunsi Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 64. Qilu Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 65. Shandong Zibo Xinda Pharmaceutical Cefuroxim Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications